Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
NRXP, NRXPW | NRX Pharmaceuticals, Inc. | Chief Financial Officer | $10K | Feb 7, 2025 | ||
ARTHQ, ARTH | Arch Therapeutics, Inc. | Chief Financial Officer | $2.83K | Aug 31, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|